Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Retatrutide (LY3437943) is a once-weekly injectable peptide developed by Eli Lilly
Quickstart Highlights Retatrutide is a first-in-class triple agonist it engages the GLP-1, GIP, and glucagon receptors at the same time [1] and has been studied for substantial weight loss and broad metabolic improvement in obesity and type 2 diabetes [2] [3]
Specifically designed for research use, this kit ensures purity, precision, and reproducibility in every preparation
Furthermore it was found that 69% of the participants in the study reduced their initial body weight by at least 10%
US$ 29.03
US$ 21.31
US$ 27.32
US$ 23.51
